Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 02:30:00 07/11/2026 am IST			5-day change	1st Jan Change
79.41 ^USD	-5.98%		-3.50%	+19.65%

30/10	DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says	MT
30/10	UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating	MT

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

2fb321e71203efd8936bf1cd658433.vb8l4mj2kbXCtLHM0dq5IzpdhLKfkcqYf0Du3SnDxsA.x81Jo1vA1_P1h8Gt_JPUGgls3uP3oIDzOG2Yt2Kcs43wyn_bBqGowbDiiQ~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

30/10	DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says	MT
30/10	UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating	MT
30/10	Raymond James Adjusts Price Target on DexCom to $97 From $94	MT
30/10	Barclays Adjusts Price Target on DexCom to $120 From $115	MT
26/10	Leerink Partners Adjusts Price Target on DexCom to $87 From $94	MT
13/10	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
12/10	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
07/10	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
17/09	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+23.6%
	ABBOTT LABORATORIES					+7.82%
	MEDTRONIC PLC					+2.77%
	STRYKER CORPORATION					+4.48%
	ESSILORLUXOTTICA					+11.41%
	CENCORA, INC.					+11.8%
	BECTON, DICKINSON AND COMPANY					-7.7%
	IDEXX LABORATORIES, INC.					+6.08%
	HOYA CORPORATION					+36.89%
	ALCON INC.					+20.39%
	Average					+11.75%
	Weighted average by Cap.					+8.87%